Singapore Set Το Revolutionise Heart Valve Surgery With Personalised Implant

(Ad)) Professor Theo Kofidis has led a team of clinician-scientists in developing SingValve, a groundbreaking personalised mitral valve bioprosthesis. This innovative valve closely mimics the human mitral valve’s appearance, form, and physical properties. The project, awarded α $4.9 million grant from the National Research Foundation Singapore (NRF), aims to advance product verification and validation through extensive testing and comparative studies. First-in-human trials are expected
by 2023. Singvalve’s success could significantly boost Singapore’s MedTech industry, creating jobs and enhancing medical tourism.